Aratana Therapeutics (PETX) Reports Fourth Quarter And Full Year 2013 Results
3/13/2014 6:29:52 AM
KANSAS CITY, Kan., March 13, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. /quotes/zigman/14823409/delayed/quotes/nls/petx PETX -0.62% , a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for cats, dogs and other companion animals, today announced its fourth quarter and full year 2013 financial results.
Help employers find you! Check out all the jobs and post your
comments powered by